Results 131 to 140 of about 19,210,102 (353)

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha   +6 more
wiley   +1 more source

A New Value for Cooperative Games on Intersection-Closed Systems [PDF]

open access: yesarXiv
We introduce a new allocation rule, the uniform-dividend value (UD-value), for cooperative games whose characteristic function is incomplete. The UD-value assigns payoffs by distributing the total surplus of each family of indistinguishable coalitions uniformly among them.
arxiv  

Rational convex cones and cyclotomic multiple zeta values [PDF]

open access: yesarXiv, 2004
In this paper, we introduce zeta values of rational convex cones, which is a generalization of cyclotomic multiple zeta values. These zeta values have integral expressions. The main theorem asserts that zeta values of cones can be expressed as linear combinations of cyclotomic multiple zeta values over some cyclotomic field.
arxiv  

Time to deterioration of patient-reported outcome endpoints in cancer clinical trials: targeted literature review and best practice recommendations

open access: yesJournal of Patient-Reported Outcomes
Background Time to deterioration (TTD) endpoints are often utilized in the analysis of patient-reported outcome (PRO) data in oncology clinical trials but different endpoint definitions and analysis frameworks exist that can impact result interpretation.
Kim Cocks   +8 more
doaj   +1 more source

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini   +11 more
wiley   +1 more source

Interpolated Schur multiple zeta values [PDF]

open access: yesarXiv, 2017
Inspired by a recent work of M. Nakasuji, O. Phuksuwan and Y. Yamasaki we combine interpolated multiple zeta values and Schur multiple zeta values into one object, which we call interpolated Schur multiple zeta values. Our main result will be a Jacobi-Trudi formula for a certain class of these new objects. This generalizes an analogous result for Schur
arxiv  

Estimating the time required to reach HPV vaccination targets across Europe

open access: yesExpert Review of Vaccines
Background Cervical cancer (CC) is one of the most common causes of cancer-related deaths in women. The World Health Organization (WHO) has called for the CC elimination as a public health priority and has urged countries to achieve a 90% vaccine ...
Ilias Gountas   +5 more
doaj   +1 more source

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

open access: yesMolecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy